108 related articles for article (PubMed ID: 15502323)
1. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
Kammerer S; Germain P; Flaig R; Peluso-Iltis C; Mitschler A; Rochel N; Gronemeyer H; Moras D
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
Klaholz BP; Mitschler A; Moras D
J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567
[TBL] [Abstract][Full Text] [Related]
3. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
4. Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor.
Bourguet W; Ruff M; Bonnier D; Granger F; Boeglin M; Chambon P; Moras D; Gronemeyer H
Protein Expr Purif; 1995 Oct; 6(5):604-8. PubMed ID: 8535152
[TBL] [Abstract][Full Text] [Related]
5. Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid.
Rochel N; Renaud JP; Ruff M; Vivat V; Granger F; Bonnier D; Lerouge T; Chambon P; Gronemeyer H; Moras D
Biochem Biophys Res Commun; 1997 Jan; 230(2):293-6. PubMed ID: 9016769
[TBL] [Abstract][Full Text] [Related]
6. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
7. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
[TBL] [Abstract][Full Text] [Related]
8. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
Germain P; Iyer J; Zechel C; Gronemeyer H
Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
[TBL] [Abstract][Full Text] [Related]
9. Overexpression, purification, and crystal structure of native ER alpha LBD.
Eiler S; Gangloff M; Duclaud S; Moras D; Ruff M
Protein Expr Purif; 2001 Jul; 22(2):165-73. PubMed ID: 11437591
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary crystallographic studies of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.
Razeto A; Pfitzner E; Becker S
Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):550-2. PubMed ID: 14993689
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
[TBL] [Abstract][Full Text] [Related]
12. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis.
Bourguet W; Andry V; Iltis C; Klaholz B; Potier N; Van Dorsselaer A; Chambon P; Gronemeyer H; Moras D
Protein Expr Purif; 2000 Jul; 19(2):284-8. PubMed ID: 10873543
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
[TBL] [Abstract][Full Text] [Related]
14. Crystallization and preliminary X-ray diffraction studies of isoform alpha1 of the human thyroid hormone receptor ligand-binding domain.
Nunes FM; Aparicio R; Santos MA; Portugal RV; Dias SM; Neves FA; Simeoni LA; Baxter JD; Webb P; Polikarpov I
Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1867-70. PubMed ID: 15388935
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a novel tetrameric complex of agonist-bound ligand-binding domain of Biomphalaria glabrata retinoid X receptor.
de Groot A; de Rosny E; Juillan-Binard C; Ferrer JL; Laudet V; Pierce RJ; Pebay-Peyroula E; Fontecilla-Camps JC; Borel F
J Mol Biol; 2005 Dec; 354(4):841-53. PubMed ID: 16274693
[TBL] [Abstract][Full Text] [Related]
16. Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.
Alvarez S; Alvarez R; Khanwalkar H; Germain P; Lemaire G; Rodríguez-Barrios F; Gronemeyer H; de Lera AR
Bioorg Med Chem; 2009 Jul; 17(13):4345-59. PubMed ID: 19482478
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability.
Wang W; Prosise WW; Chen J; Taremi SS; Le HV; Madison V; Cui X; Thomas A; Cheng KC; Lesburg CA
Protein Eng Des Sel; 2008 Jul; 21(7):425-33. PubMed ID: 18456871
[TBL] [Abstract][Full Text] [Related]
18. Structure of human TSG101 UEV domain.
Palencia A; Martinez JC; Mateo PL; Luque I; Camara-Artigas A
Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):458-64. PubMed ID: 16552148
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
Egea PF; Mitschler A; Rochel N; Ruff M; Chambon P; Moras D
EMBO J; 2000 Jun; 19(11):2592-601. PubMed ID: 10835357
[TBL] [Abstract][Full Text] [Related]
20. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
